PHARMAID Stock Overview
Engages in the manufacturing and sale of neutral glass ampoules in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Pharma Aids Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳602.90 |
| 52 Week High | ৳819.80 |
| 52 Week Low | ৳579.00 |
| Beta | 0.015 |
| 11 Month Change | -7.98% |
| 3 Month Change | -7.25% |
| 1 Year Change | -23.75% |
| 33 Year Change | 23.44% |
| 5 Year Change | 29.96% |
| Change since IPO | 30,045.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARMAID | BD Packaging | BD Market | |
|---|---|---|---|
| 7D | -3.3% | -5.6% | -0.9% |
| 1Y | -23.8% | -8.9% | -20.0% |
Return vs Industry: PHARMAID underperformed the BD Packaging industry which returned -8.9% over the past year.
Return vs Market: PHARMAID underperformed the BD Market which returned -20% over the past year.
Price Volatility
| PHARMAID volatility | |
|---|---|
| PHARMAID Average Weekly Movement | 6.0% |
| Packaging Industry Average Movement | 5.4% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in BD Market | 9.3% |
| 10% least volatile stocks in BD Market | 3.9% |
Stable Share Price: PHARMAID has not had significant price volatility in the past 3 months compared to the BD market.
Volatility Over Time: PHARMAID's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 86 | Faizul Hassan | www.pharmaaids.com |
Pharma Aids Limited engages in the manufacturing and sale of neutral glass ampoules in Bangladesh. Its products are used by pharmaceutical companies for filling liquid injections. The company was incorporated in 1981 and is based in Dhaka, Bangladesh.
Pharma Aids Limited Fundamentals Summary
| PHARMAID fundamental statistics | |
|---|---|
| Market cap | ৳1.88b |
| Earnings (TTM) | ৳67.38m |
| Revenue (TTM) | ৳431.12m |
27.9x
P/E Ratio4.4x
P/S RatioIs PHARMAID overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMAID income statement (TTM) | |
|---|---|
| Revenue | ৳431.12m |
| Cost of Revenue | ৳294.80m |
| Gross Profit | ৳136.32m |
| Other Expenses | ৳68.95m |
| Earnings | ৳67.38m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 21.59 |
| Gross Margin | 31.62% |
| Net Profit Margin | 15.63% |
| Debt/Equity Ratio | 5.6% |
How did PHARMAID perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield12%
Payout RatioDoes PHARMAID pay a reliable dividends?
See PHARMAID dividend history and benchmarks| Pharma Aids dividend dates | |
|---|---|
| Ex Dividend Date | Dec 08 2024 |
| Dividend Pay Date | Jan 23 2025 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 62 days |
Does PHARMAID pay a reliable dividends?
See PHARMAID dividend history and benchmarks